<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The sequence of the exon 1/intron 1 boundary region of the MYC gene was determined in two diffuse large cell <z:hpo ids='HP_0002665'>lymphomas</z:hpo> (DLCL), one with t(8;14) (q24;q32) and the other with t(8;22) (q24;q11) </plain></SENT>
<SENT sid="1" pm="."><plain>Both <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> had multiple mutations in this region </plain></SENT>
<SENT sid="2" pm="."><plain>Also, both <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> had mutations in the protein binding site in intron 1, which is a frequent target for mutational inactivation in endemic Burkitt's <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (eBL) </plain></SENT>
<SENT sid="3" pm="."><plain>The translocations at 8q24, and multiple mutations in the exon 1/intron 1 boundary region, are reminiscent of similar findings in eBL </plain></SENT>
<SENT sid="4" pm="."><plain>The same underlying oncogenic event that occurs in most eBLs is thus found in some DLCLs </plain></SENT>
</text></document>